Acta Med. 2004, 47: 13-18
https://doi.org/10.14712/18059694.2018.59
Anticholinergic Drugs – Functional Antidotes for the Treatment of Tabun Intoxication
References
1. J, Fusek J, Vachek J. Treatment and prophylaxis against nerve agent poisoning. ASA Newslett. 1994; 94:10–7.
2. JG, Shiloff JD, Gennings C. Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime, against tabun and soman poisoning in mice. Arch Toxicol 1987; 61:70–5.
<https://doi.org/10.1007/BF00324551>
3. E, Hornychová M. Clustering of neurobehavioral measures of toxicity. Homeostasis 1995; 36:19–25.
4. M, Maksimovic M, Kilibarda V, Jovanovic D, Savic D. Oxime-induced reactivation of acetylcholinesterase inhibited by phosphoramidates. Toxicol Lett 1996; 85:35–9.
<https://doi.org/10.1016/0378-4274(96)03634-X>
5. J, Vachek J. A comparison of the efficacy of pyridostigmine alone and the combination of pyridostigmine with anticholinergic drugs as pharmacological pretreatment of tabun-poisoned rats and mice. Toxicology 2002; 177:179–85.
<https://doi.org/10.1016/S0300-483X(02)00219-6>
6. G, Kassa J. Neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in tabun-poisoned rats. Toxicology 2003; 185:129–39.
<https://doi.org/10.1016/S0300-483X(02)00599-1>
7. Ch, Leader H, Radic Z et al. Two possible orientation of the HI-6 molecule in the reactivation of organophosphate-inhibited acetylcholinesterase. Biochem Pharmacol 2003; 66(3):387–92.
<https://doi.org/10.1016/S0006-2952(03)00237-5>
8. CG, Singer W, Harrington DG. Acute neuropathology in soman poisoned rats. Fundam Appl Toxicol 1984; 5:53–8.
9. VC, Becking GC, Cuomo V et al. The IPCS collaborative study on neurobehavioral screening methods: III. Results of proficiency studies. Neurotoxicology 1997; 18:939–46.
10. VC, Becking GC, Cuomo V et al. The IPCS collaborative study on neurobehavioral screening methods: V. Results of chemical testing. Neurotoxicology 1997; 18:969–1056.
11. VC, Tilson H, McPhail RC et al. The IPCS collaborative study on neurobehavioral screening methods: II. Protocol design and testing procedures. Neurotoxicology 1997; 18:929–38.
12. JM. Soman neurotoxicity. Fundam Appl Toxicol 1983; 1:73–83.
13. G, Artursson, E, Bucht G. Reactivation of nerve agent inhibited acetylcholinesterases by HI-6 and obidoxime. Biochem Pharmacol 1986; 35:1505–10.
<https://doi.org/10.1016/0006-2952(86)90116-4>
14. Y, Belkin M. The role of excitotoxicity in organophosphorus nerve agents central poisoning. Trends Pharmacol Sci 1997; 18:183–5.
<https://doi.org/10.1016/S0165-6147(97)89540-5>
15. Taylor P. Anticholinesterase agents. In: Hardman JG, Limbird LE, editors. The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw Hill, 1996: p.161–76.
16. LS, Testylier G, Masqueliez C, Lallement G, Monmaur P. Effects of huperzine used as pre-treatment against soman-induced seizures. Neurotoxicology 2001; 22(1):29–37.
<https://doi.org/10.1016/S0161-813X(00)00015-2>
17. C, Floresceu C. Clinical and electrophysiological study of neuropathy after organophosphorus compound poisoning. Arch Toxicol 1980; 43:305–15.
<https://doi.org/10.1007/BF00366186>
